Another brilliant post...... some very knowledgeable people on...

First 2 Last

Share
Profile

Follow
Glitterati

10,136 Posts.

2792

22/11/23

18:26

Post #: 71050839
Share
Originally posted by OzBandit: ↑

Given the recent developments and price action, NickelSearch (NIS) is poised for a breakout and upward momentum. In the spirit of centralizing valuable contributions, it's time for a general discussion thread. I'll start with ten reasons why NickelSearch (NIS) could be considered a promising investment/punt:
Diverse Resource Base: NIS holds a significant 27MT Nickel JORC resource, indicating a strong base in nickel resources.
Lithium Potential: Recent findings of high-grade lithium boulders/rocks grading over 5% Li and the presence of lithium in soil samples enhance the company's potential in the lithium market.
Proximity to Major Operations: The proximity of NIS's operations to Allkem's Mt Catlin Lithium plant (less than 10 kms away) and First Quantum's Nickel plant (less than 5 kms) suggests logistical advantages and potential synergies.
Strategic Location: NIS is situated in Australia, WA, a region known for its rich mineral deposits and supportive mining infrastructure.
Experienced Management: With Nicole Duncan, an ex-BHP and South 32 executive, at the helm, the company benefits from seasoned leadership.
Collaboration with Industry Leaders: The Non-Disclosure Agreement (NDA) signed with Allkem, a major player in the mining industry, and the technical assistance provided by Allkem, underscores industry recognition and support.
Extensive Exploration Activities: NIS is actively engaged in exploration, including sampling, mapping, and rock chip collecting, indicating a commitment to expanding its resource base.
Historical Data Reassessment: The re-assaying of 140kms of historical drilling for lithium suggests a methodical approach to leveraging existing data for new opportunities.
Infrastructure Advantage: The presence of excellent infrastructure, including road, rail, and port access, particularly the proximity to Esperance Port, enhances operational efficiency.
Financial Position: With a market capitalization of only $21 million and $3 million in cash, along with the possibility of an additional $1.1 million influx, NIS presents a potentially undervalued investment opportunity in the resources sector.

DYOR & GLTAH

Expand

Another brilliant post...... some very knowledgeable people on this forum, keep it coming
NIS Price at posting: 13.5¢ Sentiment: Buy Disclosure: Held
9 Upvote

0 Great analysis

Reply

Top Stories

MSB

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

SPR

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

SRL

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

OCC

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

PL3

Patagonia looks to raise $2.15M for South American exploration and development

There are more pages in this discussion • 317 more messages in this thread...

First 2 Last

Add NIS (ASX) to my watchlist

(20min delay)
Last 2.0¢		Change 0.000(0.00%)		Mkt cap ! $4.270M

Open	High	Low	Value	Volume
2.0¢	2.0¢	2.0¢	$105	5.226K

Buyers (Bids)

No.	Vol.	Price($)
1	134606	1.9¢

Sellers (Offers)

Price($)	Vol.	No.
2.0¢	47144	2

View Market Depth

No.	Vol.	Price($)
1	134606	0.019
1	500000	0.018
6	837730	0.017
7	896232	0.016
4	326661	0.015

Price($)	Vol.	No.
0.020	47144	2
0.023	213690	2
0.024	1000000	2
0.025	151341	2
0.035	26750	1

Last trade - 10.14am 09/07/2024 (20 minute delay)

NIS (ASX) Chart

Another brilliant post...... some very knowledgeable people on...

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

Patagonia looks to raise $2.15M for South American exploration and development

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Another brilliant post...... some very knowledgeable people on...

Top Stories

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

Patagonia looks to raise $2.15M for South American exploration and development

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News